D. E. Shaw & Co., Inc. Abiomed Inc Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $79,294 - $98,577	-327 Reduced 8.66%	3,448 $847,000
Q2 2022 Aug 15, 2022	BUY	$224.73 - $338.64 $455,078 - $685,746	2,025 Added 115.71%	3,775 $934,000
Q1 2022 May 16, 2022	BUY	$277.25 - $366.29 $32,992 - $43,588	119 Added 7.3%	1,750 $580,000
Q4 2021 Feb 14, 2022	BUY	$300.63 - $371.35 $60,126 - $74,270	200 Added 13.98%	1,631 $586,000
Q3 2021 Nov 15, 2021	BUY	$310.19 - $376.2 $124,076 - $150,480	400 Added 38.8%	1,431 $466,000
Q2 2021 Aug 16, 2021	SELL	$262.71 - $351.17 $324,972 - $434,397	-1,237 Reduced 54.54%	1,031 $322,000
Q1 2021 May 17, 2021	BUY	$285.92 - $355.13 $367,693 - $456,697	1,286 Added 130.96%	2,268 $722,000
Q4 2020 Feb 16, 2021	SELL	$251.88 - $324.2 $604,512 - $778,080	-2,400 Reduced 70.96%	982 $318,000
Q3 2020 Nov 16, 2020	SELL	$255.22 - $317.0 $1.19 Million - $1.48 Million	-4,653 Reduced 57.91%	3,382 $937,000
Q2 2020 Aug 14, 2020	SELL	$141.4 - $257.09 $389,698 - $708,540	-2,756 Reduced 25.54%	8,035 $1.94 Million
Q1 2020 May 15, 2020	SELL	$130.51 - $196.01 $312,179 - $468,855	-2,392 Reduced 18.14%	10,791 $1.57 Million
Q4 2019 Feb 14, 2020	SELL	$159.31 - $223.54 $9.08 Million - $12.7 Million	-57,002 Reduced 81.22%	13,183 $2.25 Million
Q3 2019 Nov 14, 2019	BUY	$175.89 - $279.23 $9.54 Million - $15.2 Million	54,257 Added 340.64%	70,185 $12.5 Million
Q2 2019 Aug 14, 2019	BUY	$250.96 - $284.94 $3.39 Million - $3.85 Million	13,523 Added 562.29%	15,928 $4.15 Million
Q1 2019 May 15, 2019	SELL	$276.39 - $362.25 $1.82 Million - $2.39 Million	-6,587 Reduced 73.25%	2,405 $687,000
Q4 2018 Feb 14, 2019	BUY	$281.08 - $444.25 $596,451 - $942,698	2,122 Added 30.89%	8,992 $2.92 Million
Q3 2018 Nov 14, 2018	SELL	$354.53 - $449.75 $16.4 Million - $20.8 Million	-46,314 Reduced 87.08%	6,870 $3.09 Million
Q2 2018 Aug 14, 2018	BUY	$278.07 - $446.21 $8.25 Million - $13.2 Million	29,678 Added 126.26%	53,184 $21.8 Million
Q1 2018 May 15, 2018	SELL	$192.49 - $295.85 $9.24 Million - $14.2 Million	-48,025 Reduced 67.14%	23,506 $6.84 Million
Q4 2017 Feb 14, 2018	BUY	$168.78 - $199.74 $2.63 Million - $3.11 Million	15,588 Added 27.86%	71,531 $13.4 Million
Q3 2017 Nov 14, 2017	BUY	$145.39 - $168.6 $8.13 Million - $9.43 Million	55,943	55,943 $9.43 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account